These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 16361981

  • 1. Testotoxicosis: current viewpoint.
    Reiter EO, Norjavaara E.
    Pediatr Endocrinol Rev; 2005 Dec; 3(2):77-86. PubMed ID: 16361981
    [Abstract] [Full Text] [Related]

  • 2. Treatment of familial male-limited precocious puberty with bicalutamide and anastrozole.
    Kreher NC, Pescovitz OH, Delameter P, Tiulpakov A, Hochberg Z.
    J Pediatr; 2006 Sep; 149(3):416-20. PubMed ID: 16939760
    [Abstract] [Full Text] [Related]

  • 3. Treatment of familial male-limited precocious puberty (testotoxicosis) with anastrozole and bicalutamide in a boy with a novel mutation in the luteinizing hormone receptor.
    Mitre N, Lteif A.
    J Pediatr Endocrinol Metab; 2009 Dec; 22(12):1163-7. PubMed ID: 20333877
    [Abstract] [Full Text] [Related]

  • 4. Bicalutamide and third-generation aromatase inhibitors in testotoxicosis.
    Lenz AM, Shulman D, Eugster EA, Rahhal S, Fuqua JS, Pescovitz OH, Lewis KA.
    Pediatrics; 2010 Sep; 126(3):e728-33. PubMed ID: 20713483
    [Abstract] [Full Text] [Related]

  • 5. Testotoxicosis: Report of Two Cases, One with a Novel Mutation in LHCGR Gene.
    Özcabı B, Tahmiscioğlu Bucak F, Ceylaner S, Özcan R, Büyükünal C, Ercan O, Tüysüz B, Evliyaoğlu O.
    J Clin Res Pediatr Endocrinol; 2015 Sep; 7(3):242-8. PubMed ID: 26831561
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness of anastrozole and cyproterone acetate in two brothers with familial male precocious puberty.
    Eyssette-Guerreau S, Pinto G, Sultan A, Le Merrer M, Sultan C, Polak M.
    J Pediatr Endocrinol Metab; 2008 Oct; 21(10):995-1002. PubMed ID: 19209621
    [Abstract] [Full Text] [Related]

  • 7. Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole.
    Almeida MQ, Brito VN, Lins TS, Guerra-Junior G, de Castro M, Antonini SR, Arnhold IJ, Mendonca BB, Latronico AC.
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):93-8. PubMed ID: 18088394
    [Abstract] [Full Text] [Related]

  • 8. Effect of Antiandrogen, Aromatase Inhibitor, and Gonadotropin-releasing Hormone Analog on Adult Height in Familial Male Precocious Puberty.
    Leschek EW, Flor AC, Bryant JC, Jones JV, Barnes KM, Cutler GB.
    J Pediatr; 2017 Nov; 190():229-235. PubMed ID: 29144249
    [Abstract] [Full Text] [Related]

  • 9. [Testotoxicosis].
    Fuse H, Akashi T, Watanabe A.
    Nihon Rinsho; 2006 Jun 28; Suppl 2():628-31. PubMed ID: 16817479
    [No Abstract] [Full Text] [Related]

  • 10. Combined treatment with bicalutamide and anastrozole in a young boy with peripheral precocious puberty due to McCune-Albright Syndrome.
    Tessaris D, Matarazzo P, Mussa A, Tuli G, Verna F, Fiore L, Lala R.
    Endocr J; 2012 Jun 28; 59(2):111-7. PubMed ID: 22068112
    [Abstract] [Full Text] [Related]

  • 11. Effective aromatase inhibition by anastrozole in a patient with gonadotropin-independent precocious puberty in McCune-Albright syndrome.
    Roth C, Freiberg C, Zappel H, Albers N.
    J Pediatr Endocrinol Metab; 2002 Jun 28; 15 Suppl 3():945-8. PubMed ID: 12199354
    [Abstract] [Full Text] [Related]

  • 12. Treatment of familial male precocious puberty with spironolactone and testolactone.
    Laue L, Kenigsberg D, Pescovitz OH, Hench KD, Barnes KM, Loriaux DL, Cutler GB.
    N Engl J Med; 1989 Feb 23; 320(8):496-502. PubMed ID: 2492636
    [Abstract] [Full Text] [Related]

  • 13. Reply; Testotoxicosis: Report of Two Cases, One with a Novel Mutation in LHCGR Gene.
    Evliyaoğlu O.
    J Clin Res Pediatr Endocrinol; 2016 Mar 05; 8(1):107. PubMed ID: 26757946
    [No Abstract] [Full Text] [Related]

  • 14. Preclinical diagnosis of testotoxicosis in a boy with an activating mutation of the luteinizing hormone receptor.
    Teles M, Brito VN, Arnhold IJ, Mendonca BB, Latronico AC.
    J Pediatr Endocrinol Metab; 2006 Apr 05; 19(4):541-4. PubMed ID: 16759041
    [Abstract] [Full Text] [Related]

  • 15. Bicalutamide plus anastrozole for the treatment of gonadotropin-independent precocious puberty in boys with testotoxicosis: a phase II, open-label pilot study (BATT).
    Reiter EO, Mauras N, McCormick K, Kulshreshtha B, Amrhein J, De Luca F, O'Brien S, Armstrong J, Melezinkova H.
    J Pediatr Endocrinol Metab; 2010 Oct 05; 23(10):999-1009. PubMed ID: 21158211
    [Abstract] [Full Text] [Related]

  • 16. Gonadotropin-independent precocious puberty.
    Holland FJ.
    Endocrinol Metab Clin North Am; 1991 Mar 05; 20(1):191-210. PubMed ID: 1903104
    [Abstract] [Full Text] [Related]

  • 17. Strategies for maximizing growth in puberty in children with short stature.
    Mauras N.
    Endocrinol Metab Clin North Am; 2009 Sep 05; 38(3):613-24. PubMed ID: 19717007
    [Abstract] [Full Text] [Related]

  • 18. Treatment with the aromatase inhibitor letrozole during adolescence increases near-final height in boys with constitutional delay of puberty.
    Hero M, Wickman S, Dunkel L.
    Clin Endocrinol (Oxf); 2006 May 05; 64(5):510-3. PubMed ID: 16649968
    [Abstract] [Full Text] [Related]

  • 19. [The use of aromatase inhibitors in children].
    Eyal O, Naugolny L, Weintrob N.
    Harefuah; 2009 Dec 05; 148(12):825-30, 855. PubMed ID: 20088436
    [Abstract] [Full Text] [Related]

  • 20. A Case of Familial Male-limited Precocious Puberty with a Novel Mutation.
    Gurnurkar S, DiLillo E, Carakushansky M.
    J Clin Res Pediatr Endocrinol; 2021 Jun 02; 13(2):239-244. PubMed ID: 32757547
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.